Portal:Lipids/PathwayList

From WikiPathways

Revision as of 13:04, 29 January 2019 (view source) DeSl (Talk | contribs) ← Previous diff		Current revision (14:39, 1 October 2020) (view source) DeSl (Talk | contribs)
(10 intermediate revisions not shown.)
Line 1:		Line 1:
-	==== Create new pathways ====	+	=== Existing pathways ===
-	* Public resources for pathway information: [http://lipidmaps.org/ LIPID MAPS] and [http://www.swisslipids.org/ SwissLipids].	+	Pathways which have been approved for data analysis can be found on the [https://www.wikipathways.org/index.php/Portal:Lipids/FeaturedPathways Featured pathway] page.
		+	We have split these up in 7 groups (Sphingolipids, Eicosanoids, Glycerolipids and Glycerophospholipids, Phosphatidylglycerides, Fatty Acids, Cholesterol, General Pathways related to Lipids).
-	* See our Help section for [[:Help:New_Contributor_Quickstart|New Contributor QuickStart]], [[:Help:Guidelines_EditorPalette|Editor's Palette Guide]] and [[:Help:Guidelines|Guidelines for Contributors]].	+	==== Extend existing (approved) pathways with new literature ====
-	==== Improve existing pathways ====	+	* [https://doi.org/10.1002/cm.21067 More proteins], [https://doi.org/10.1002/bies.201300064 localisation], details on regulation of (endocytic) membrane traffic [https://doi.org/10.1111/febs.12116] and [https://doi.org/10.1242/jcs.02855] by phosphoinositide 3-kinases, and [https://doi.org/10.1016/j.febslet.2012.04.046 activity and tumor suppression] thereof for [https://www.wikipathways.org/index.php/Pathway:WP4971 WP4971].
		+
		+	==== Update existing (not yet approved) pathways ====
	{|style="background-color:#f4f9fa"		{|style="background-color:#f4f9fa"
-	|[[:Pathway:WP4345|GP generic (mouse)]]	+	|[[:Pathway:WP4690|Sphingolipid Metabolism (integrated pathway) (mouse)]]
-	|[[:Pathway:WP4491|Elongation of (very) long chain fatty acids (mouse)]]	+
	|-		|-
-	|[[:Pathway:WP4350|Omega 3&6 FA synthesis (mouse)]]	+	|[[:Pathway:WP4491|Elongation of (very) long chain fatty acids (mouse)]]
-	|[[:Pathway:WP4351|Omega 9 FA synthesis (mouse)]]	+
-	|-	+
-	|[[:Pathway:WP4344|Sphingolipid Pathway (mouse)]]	+
-		+
	|}		|}
		+
		+	=== Create new pathways ===
		+	* Public resources for pathway information: [http://lipidmaps.org/ LIPID MAPS] and [http://www.swisslipids.org/ SwissLipids].
		+
		+	* See our Help section for [[:Help:New_Contributor_Quickstart|New Contributor QuickStart]], [[:Help:Guidelines_EditorPalette|Editor's Palette Guide]] and [[:Help:Guidelines|Guidelines for Contributors]].
		+
		+	==== Start a new pathway! ====
		+
		+	* [https://doi.org/10.1016/j.chembiol.2004.03.025 Phosphoinositide Signaling]
		+	* [http://dx.doi.org/10.1016/j.cell.2017.07.029 PI3-K in Human diseases]
		+	* [https://doi.org/10.3390/ijms19123931 Class I PI3-K Isoforms in Endometrial Cancer]
		+	* [https://en.wikipedia.org/wiki/Inositol_trisphosphate_receptor Inositol trisphosphate receptor]
	=== Contact us ===		=== Contact us ===

---

Current revision

Contents 1 Existing pathways 1.1 Extend existing (approved) pathways with new literature 1.2 Update existing (not yet approved) pathways 2 Create new pathways 2.1 Start a new pathway! 3 Contact us 4 How to add a pathway to the portal

Existing pathways

Pathways which have been approved for data analysis can be found on the Featured pathway page. We have split these up in 7 groups (Sphingolipids, Eicosanoids, Glycerolipids and Glycerophospholipids, Phosphatidylglycerides, Fatty Acids, Cholesterol, General Pathways related to Lipids).

Extend existing (approved) pathways with new literature

• More proteins, localisation, details on regulation of (endocytic) membrane traffic [1] and [2] by phosphoinositide 3-kinases, and activity and tumor suppression thereof for WP4971.

Update existing (not yet approved) pathways

Sphingolipid Metabolism (integrated pathway) (mouse)

Elongation of (very) long chain fatty acids (mouse)

Create new pathways

• Public resources for pathway information: LIPID MAPS and SwissLipids.

• See our Help section for New Contributor QuickStart, Editor's Palette Guide and Guidelines for Contributors.

Start a new pathway!

• Phosphoinositide Signaling
• PI3-K in Human diseases
• Class I PI3-K Isoforms in Endometrial Cancer
• Inositol trisphosphate receptor

Contact us

Send questions about WikiPathways to the wikipathways-discuss mailing list.

How to add a pathway to the portal

The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact the administrator.